Horrell Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Horrell Capital Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-300	Closed	-$65K	–	209
2021 Q1	$65K	Hold	300	–	–	0.03%	108
2020 Q4	$35K	Hold	300	–	–	0.02%	115
2020 Q3	$29K	Buy	300 +100	+50%	+$11.5K	0.01%	114
2020 Q2	$25K	Sell	200 -100	-33%	-$11.3K	0.01%	116
2020 Q1	$26K	Hold	300	–	–	0.02%	110
2019 Q4	$31K	Sell	300 -100	-25%	-$11.2K	0.02%	113
2019 Q3	$46K	Hold	400	–	–	0.02%	111
2019 Q2	$69K	Hold	400	–	–	0.03%	99
2019 Q1	$67K	Hold	400	–	–	0.03%	102
2018 Q4	$39K	Buy	400 +100	+33%	+$13.1K	0.02%	112
2018 Q3	$52K	Buy	300 +200	+200%	+$28.8K	0.03%	108
2018 Q2	$14K	Hold	100	–	–	0.01%	133
2018 Q1	$11K	Buy	100 +40	+67%	+$5.03K	0.01%	137
2017 Q4	$8K	Buy	+60	New	+$7.05K	﹤0.01%	146

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Horrell Capital Management's GWPH Position: Q2 2021 in Review

Horrell Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 300 shares — an estimated $65K sold.

Horrell Capital Management first reported a position in GWPH in Q4 2017 and held it in 14 quarters. The position peaked at $69K in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Horrell Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Horrell Capital Management sold 300 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $65K.
Horrell Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 14 quarters.
Horrell Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $69K in Q2 2019.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Horrell Capital Management's 13F filing for Q2 2021, filed 3 Aug 2021.